首页 > 最新文献

Antibiotics-Basel最新文献

英文 中文
Revisiting Antibiotic-Impregnated Cement Spacer for Diabetic Osteomyelitis of the Foot. 对糖尿病足部骨髓炎的抗生素浸没水泥垫片的重新研究。
IF 4.3 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-12-01 DOI: 10.3390/antibiotics13121153
Farouk Khury, Ihab Karkabi, Elias Mazzawi, Doron Norman, Eyal A Melamed, Eli Peled

Introduction: Despite the rising global awareness and improvement of socioeconomic and living standards, the prevalence of diabetic osteomyelitis (DOM) and its complications has been increasing rapidly. This study aims to investigate the long-term prognosis of DOM of the foot treated using antibiotic-impregnated cement spacer (ACS) and the contributing risk factors for reoperation.

Methods and materials: We retrospectively reviewed the data of 55 diabetic patients with Meggitt-Wagner Grade IIB wounds diagnosed with osteomyelitis of the foot, treated in our institution with excessive debridement, excision of the infected tissue, and implantation of antibiotic-impregnated cement spacer fixed with a Kirschner wire. Descriptive statistics, including patient demographics, were analyzed. Statistical analysis was performed using point-biserial correlation and a Chi-square test with Cramer's V effect-size estimation to determine the relationship between reoperation and various parameters.

Results: 55 patients (36 (65.45%) males and 19 (34.55%) females) with a median age of 64 (39-84) years were thoroughly analyzed throughout a median follow-up of 884 days (2-4671 days). Of the entire cohort, 29 (52.72%) patients achieved primary successful infection eradication without any further intervention, and 8 (14.54%) patients were successfully treated using a secondary procedure. More than half of the reoperated patients underwent the secondary intervention within less than a month after the primary ACS. When assessing correlation, age (r = 0.28, p = 0.04), gender (r = 0.31, p = 0.02), Staphylococcus aureus (r = -0.10, p = 0.04), and the use of gentamicin-only antibiotic cement spacer (r = 0.34, p = 0.01) demonstrated statistically significant correlation to reoperation. 89.18% of the patients who achieved infection eradication did not undergo cement removal.

Conclusions: ACS has shown excellent results in eradicating bone infection with up to 7.23 years of follow-up, acting as a structural stabilizer, preventing soft tissue contractures, and delivering highly concentrated local antibiotic treatment both to soft tissue and bone. Regardless, specific factors should be thoroughly evaluated prior to surgery, as advancing age, gender, and the use of gentamicin-only antibiotics appear to be positively associated with a higher likelihood of reoperation. Conversely, infections caused by cultured Staphylococcus aureus seem to be inversely related to reoperation.

导论:尽管全球对糖尿病的认识不断提高,社会经济和生活水平不断提高,但糖尿病性骨髓炎(DOM)及其并发症的患病率仍在迅速上升。本研究旨在探讨抗生素浸渍水泥间隔剂(ACS)治疗足部DOM的远期预后及影响再手术的危险因素。方法和材料:我们回顾性回顾了55例诊断为足部骨髓炎的Meggitt-Wagner级IIB级伤口的糖尿病患者的资料,这些患者在我院接受了过度清创、切除感染组织和植入抗生素浸透的水泥间隔物并用克氏针固定。描述性统计,包括患者人口统计学分析。采用点双列相关和卡方检验(Cramer's V效应量估计)进行统计分析,确定再手术与各参数的关系。结果:55例患者(男性36例(65.45%),女性19例(34.55%),中位年龄64(39 ~ 84)岁,中位随访884天(2 ~ 4671天)。在整个队列中,29例(52.72%)患者在没有任何进一步干预的情况下成功根除了感染,8例(14.54%)患者通过二次手术成功治疗。超过一半的再手术患者在原发性ACS发生后不到一个月的时间内接受了二次干预。在评估相关性时,年龄(r = 0.28, p = 0.04)、性别(r = 0.31, p = 0.02)、金黄色葡萄球菌(r = -0.10, p = 0.04)和使用庆大霉素抗生素水泥间隔剂(r = 0.34, p = 0.01)与再次手术的相关性有统计学意义。89.18%获得感染根除的患者没有进行骨水泥清除。结论:经过长达7.23年的随访,ACS在根治骨感染、作为结构稳定剂、防止软组织挛缩、给予软组织和骨高度集中的局部抗生素治疗方面显示出优异的效果。无论如何,手术前应彻底评估具体因素,因为年龄、性别和仅使用庆大霉素的抗生素似乎与更高的再手术可能性正相关。相反,培养金黄色葡萄球菌引起的感染似乎与再次手术呈负相关。
{"title":"Revisiting Antibiotic-Impregnated Cement Spacer for Diabetic Osteomyelitis of the Foot.","authors":"Farouk Khury, Ihab Karkabi, Elias Mazzawi, Doron Norman, Eyal A Melamed, Eli Peled","doi":"10.3390/antibiotics13121153","DOIUrl":"https://doi.org/10.3390/antibiotics13121153","url":null,"abstract":"<p><strong>Introduction: </strong>Despite the rising global awareness and improvement of socioeconomic and living standards, the prevalence of diabetic osteomyelitis (DOM) and its complications has been increasing rapidly. This study aims to investigate the long-term prognosis of DOM of the foot treated using antibiotic-impregnated cement spacer (ACS) and the contributing risk factors for reoperation.</p><p><strong>Methods and materials: </strong>We retrospectively reviewed the data of 55 diabetic patients with Meggitt-Wagner Grade IIB wounds diagnosed with osteomyelitis of the foot, treated in our institution with excessive debridement, excision of the infected tissue, and implantation of antibiotic-impregnated cement spacer fixed with a Kirschner wire. Descriptive statistics, including patient demographics, were analyzed. Statistical analysis was performed using point-biserial correlation and a Chi-square test with Cramer's V effect-size estimation to determine the relationship between reoperation and various parameters.</p><p><strong>Results: </strong>55 patients (36 (65.45%) males and 19 (34.55%) females) with a median age of 64 (39-84) years were thoroughly analyzed throughout a median follow-up of 884 days (2-4671 days). Of the entire cohort, 29 (52.72%) patients achieved primary successful infection eradication without any further intervention, and 8 (14.54%) patients were successfully treated using a secondary procedure. More than half of the reoperated patients underwent the secondary intervention within less than a month after the primary ACS. When assessing correlation, age (r = 0.28, <i>p</i> = 0.04), gender (r = 0.31, <i>p</i> = 0.02), <i>Staphylococcus aureus</i> (r = -0.10, <i>p</i> = 0.04), and the use of gentamicin-only antibiotic cement spacer (r = 0.34, <i>p</i> = 0.01) demonstrated statistically significant correlation to reoperation. 89.18% of the patients who achieved infection eradication did not undergo cement removal.</p><p><strong>Conclusions: </strong>ACS has shown excellent results in eradicating bone infection with up to 7.23 years of follow-up, acting as a structural stabilizer, preventing soft tissue contractures, and delivering highly concentrated local antibiotic treatment both to soft tissue and bone. Regardless, specific factors should be thoroughly evaluated prior to surgery, as advancing age, gender, and the use of gentamicin-only antibiotics appear to be positively associated with a higher likelihood of reoperation. Conversely, infections caused by cultured <i>Staphylococcus aureus</i> seem to be inversely related to reoperation.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 12","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11672849/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevention and Modern Strategies for Managing Methicillin-Resistant Staphylococcal Infections in Prosthetic Joint Infections (PJIs). 人工关节感染(PJIs)中耐甲氧西林葡萄球菌感染的预防和现代管理策略。
IF 4.3 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-12-01 DOI: 10.3390/antibiotics13121151
Karolina Kraus, Paweł Mikziński, Jarosław Widelski, Emil Paluch

Periprosthetic joint infections (PJIs) are a dangerous complication of joint replacement surgeries which have become much more common in recent years (mostly hip and knee replacement surgeries). Such a condition can lead to many health issues and often requires reoperation. Staphylococci is a bacterial group most common in terms of the pathogens causing PJIs. S. aureus and coagulase-negative staphylococci are found in around two-thirds of PJI cases. Recently, the numbers of staphylococci that cause such infections and that are methicillin-resistant are increasing. This trend leads to difficulties in the treatment and prevention of such infections. That is why MRSA and MRSE groups require extraordinary attention when dealing with PJIs in order to successfully treat them. Controlling carriage, using optimal prosthetic materials, and implementing perioperative antimicrobial prophylaxis are crucial strategies in infection prevention and are as essential as quick diagnosis and effective targeted treatment. The comprehensive professional procedures presented in this review show how to deal with such cases.

假体周围关节感染(PJIs)是关节置换术的危险并发症,近年来(主要是髋关节和膝关节置换术)变得越来越常见。这种情况会导致许多健康问题,通常需要再次手术。葡萄球菌是引起PJIs的病原体中最常见的细菌群。在大约三分之二的PJI病例中发现金黄色葡萄球菌和凝固酶阴性葡萄球菌。最近,引起这类感染和耐甲氧西林的葡萄球菌的数量正在增加。这一趋势给治疗和预防这类感染带来了困难。这就是为什么MRSA和MRSE组在处理pji时需要特别注意才能成功治疗它们的原因。控制携带、使用最佳假体材料和实施围手术期抗菌素预防是预防感染的关键策略,与快速诊断和有效的靶向治疗一样重要。在这篇综述中提出的全面的专业程序显示了如何处理这类情况。
{"title":"Prevention and Modern Strategies for Managing Methicillin-Resistant Staphylococcal Infections in Prosthetic Joint Infections (PJIs).","authors":"Karolina Kraus, Paweł Mikziński, Jarosław Widelski, Emil Paluch","doi":"10.3390/antibiotics13121151","DOIUrl":"https://doi.org/10.3390/antibiotics13121151","url":null,"abstract":"<p><p>Periprosthetic joint infections (PJIs) are a dangerous complication of joint replacement surgeries which have become much more common in recent years (mostly hip and knee replacement surgeries). Such a condition can lead to many health issues and often requires reoperation. Staphylococci is a bacterial group most common in terms of the pathogens causing PJIs. <i>S. aureus</i> and coagulase-negative staphylococci are found in around two-thirds of PJI cases. Recently, the numbers of staphylococci that cause such infections and that are methicillin-resistant are increasing. This trend leads to difficulties in the treatment and prevention of such infections. That is why MRSA and MRSE groups require extraordinary attention when dealing with PJIs in order to successfully treat them. Controlling carriage, using optimal prosthetic materials, and implementing perioperative antimicrobial prophylaxis are crucial strategies in infection prevention and are as essential as quick diagnosis and effective targeted treatment. The comprehensive professional procedures presented in this review show how to deal with such cases.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 12","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11672861/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AcrAB Efflux Pump Plays a Crucial Role in Bile Salts Resistance and Pathogenesis of Klebsiella pneumoniae. AcrAB外排泵在肺炎克雷伯菌胆盐耐药及发病机制中起关键作用。
IF 4.3 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-11-29 DOI: 10.3390/antibiotics13121146
Rundong Shu, Ge Liu, Yunyu Xu, Bojun Liu, Zhi Huang, Hui Wang

Bile salts possess innate antibacterial properties and can cause significant damage to bacteria. To survive in the mammalian gut, Klebsiella pneumoniae has developed mechanisms to tolerate bile salts; however, the specific mechanisms remain unclear. Transposon library screening revealed that the efflux pump AcrAB is involved in bile salt resistance. acrA and acrB mutants exhibited high sensitivity not only to bile salts but also to SDS and various antibiotics, with a switch-loop, comprising residues G615, F616, A617, and G618, proving to be crucial in this process. A colonization defect of acrA and acrB mutants was demonstrated to be located in the mouse small intestine, where the bile salt concentration is higher compared to the large intestine. Additionally, both acrA and acrB mutants displayed reduced virulence in the Galleria mellonella model. In conclusion, our results suggest that the Resistance-Nodulation-Cell Division efflux pump serves as a critical determinant in the pathogenesis of K. pneumoniae through various aspects.

胆汁盐具有天生的抗菌特性,可对细菌造成重大损害。为了在哺乳动物肠道中生存,肺炎克雷伯菌已经发展出耐受胆汁盐的机制;然而,具体机制尚不清楚。转座子文库筛选显示外排泵AcrAB参与胆盐耐药。acrA和acrB突变体不仅对胆盐具有高敏感性,而且对SDS和各种抗生素也具有高敏感性,其中一个由残基G615、F616、A617和G618组成的开关环在这一过程中起着至关重要的作用。acrA和acrB突变体的定植缺陷被证明位于小鼠小肠中,与大肠相比,小肠中的胆盐浓度更高。此外,acrA和acrB突变体在mellonella模型中均表现出毒性降低。总之,我们的研究结果表明,抗性-结节化-细胞分裂外排泵在肺炎克雷伯菌的发病过程中从各个方面起着关键的决定作用。
{"title":"AcrAB Efflux Pump Plays a Crucial Role in Bile Salts Resistance and Pathogenesis of <i>Klebsiella pneumoniae</i>.","authors":"Rundong Shu, Ge Liu, Yunyu Xu, Bojun Liu, Zhi Huang, Hui Wang","doi":"10.3390/antibiotics13121146","DOIUrl":"https://doi.org/10.3390/antibiotics13121146","url":null,"abstract":"<p><p>Bile salts possess innate antibacterial properties and can cause significant damage to bacteria. To survive in the mammalian gut, <i>Klebsiella pneumoniae</i> has developed mechanisms to tolerate bile salts; however, the specific mechanisms remain unclear. Transposon library screening revealed that the efflux pump AcrAB is involved in bile salt resistance. <i>acrA</i> and <i>acrB</i> mutants exhibited high sensitivity not only to bile salts but also to SDS and various antibiotics, with a switch-loop, comprising residues G615, F616, A617, and G618, proving to be crucial in this process. A colonization defect of <i>acrA</i> and <i>acrB</i> mutants was demonstrated to be located in the mouse small intestine, where the bile salt concentration is higher compared to the large intestine. Additionally, both <i>acrA</i> and <i>acrB</i> mutants displayed reduced virulence in the <i>Galleria mellonella</i> model. In conclusion, our results suggest that the Resistance-Nodulation-Cell Division efflux pump serves as a critical determinant in the pathogenesis of <i>K. pneumoniae</i> through various aspects.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 12","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11672700/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antimicrobial Stewardship Intervention for the Family Caregiver Attending Primary Health Care Setting: A Quasi-Experimental Study. 抗菌药物管理干预家庭护理人员参加初级卫生保健设置:一项准实验研究。
IF 4.3 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-11-29 DOI: 10.3390/antibiotics13121145
Ammena Y Binsaleh, Mahmoud S Abdallah, Basma Mohamed Osman, Mostafa M Bahaa, Nawal Alsubaie, Thanaa A Elmasry, Mohamed Yasser, Mamdouh Eldesoqui, Abdel-Naser Abdel-Atty Gadallah, Manal A Hamouda, Nashwa Eltantawy, Fatma A Mokhtar, Ramy M El Sabaa

Background: Antimicrobial resistance (AMR) has been identified as one of the top ten public health threats facing humanity. Aim: The purpose of this study was to assess the effect of an antimicrobial stewardship educational intervention on family caregivers' knowledge and practices in primary healthcare settings in Egypt. Methods: A quasi-experimental, one-group pretest-posttest design involving a sample of 300 family caregivers attending family health centers. The data were collected using questionnaires that assessed caregiver knowledge and self-reported practices regarding AMR before and after the intervention (primary outcomes). The intervention combined tailored knowledge and practice components that carefully evaluated participants' knowledge regarding AMR, health risk, antibiotic usage, and prevention of infection. Furthermore, their practice of using antibiotics, including previous antibiotic exposure, their antibiotic use during the past year, reasons for taking antibiotics, ways of obtaining antibiotics, and reasons for discontinuing of antibiotic therapy were also recorded. Results: The pre-intervention assessment revealed poor knowledge and practice regarding antibiotic use. Post-intervention, mean knowledge scores increased significantly from 18.36 to 23.28 (t = 19.5, p < 0.0001), while mean practice scores improved from 9.83 to 12.37 (t = 6.4, p < 0.0001). Conclusions: The intervention successfully improved caregivers' knowledge and practices regarding AMR. However, there are some limitations that could affect the generalization, and the impact of the results such as the relatively small sample size recruited from a single center, lack of a control group, reliance on self-reported data, and lack of long-term follow-up. Future studies should aim to address these constraints in order to assess the intervention's effectiveness.

背景:抗菌素耐药性(AMR)已被确定为人类面临的十大公共卫生威胁之一。目的:本研究的目的是评估抗菌药物管理教育干预对埃及初级卫生保健机构家庭护理人员的知识和实践的影响。方法:采用准实验、一组前测后测设计,选取300名在家庭保健中心就诊的家庭照顾者为样本。数据是通过问卷收集的,该问卷评估了护理者在干预前后关于AMR的知识和自我报告的做法(主要结果)。干预措施结合了量身定制的知识和实践组成部分,仔细评估了参与者关于抗菌素耐药性、健康风险、抗生素使用和预防感染的知识。此外,还记录了他们使用抗生素的做法,包括以前的抗生素暴露情况、过去一年的抗生素使用情况、服用抗生素的原因、获得抗生素的方式以及停止抗生素治疗的原因。结果:干预前评估显示对抗生素使用的知识和实践不足。干预后,知识平均分由18.36分提高到23.28分(t = 19.5, p < 0.0001),实践平均分由9.83分提高到12.37分(t = 6.4, p < 0.0001)。结论:干预成功地提高了护理人员对抗菌素耐药性的认识和实践。然而,有一些限制可能会影响推广和结果的影响,例如从单个中心招募的样本量相对较小,缺乏对照组,依赖于自我报告的数据,以及缺乏长期随访。未来的研究应着眼于解决这些限制,以评估干预措施的有效性。
{"title":"Antimicrobial Stewardship Intervention for the Family Caregiver Attending Primary Health Care Setting: A Quasi-Experimental Study.","authors":"Ammena Y Binsaleh, Mahmoud S Abdallah, Basma Mohamed Osman, Mostafa M Bahaa, Nawal Alsubaie, Thanaa A Elmasry, Mohamed Yasser, Mamdouh Eldesoqui, Abdel-Naser Abdel-Atty Gadallah, Manal A Hamouda, Nashwa Eltantawy, Fatma A Mokhtar, Ramy M El Sabaa","doi":"10.3390/antibiotics13121145","DOIUrl":"https://doi.org/10.3390/antibiotics13121145","url":null,"abstract":"<p><p><b>Background:</b> Antimicrobial resistance (AMR) has been identified as one of the top ten public health threats facing humanity. <b>Aim:</b> The purpose of this study was to assess the effect of an antimicrobial stewardship educational intervention on family caregivers' knowledge and practices in primary healthcare settings in Egypt. <b>Methods:</b> A quasi-experimental, one-group pretest-posttest design involving a sample of 300 family caregivers attending family health centers. The data were collected using questionnaires that assessed caregiver knowledge and self-reported practices regarding AMR before and after the intervention (primary outcomes). The intervention combined tailored knowledge and practice components that carefully evaluated participants' knowledge regarding AMR, health risk, antibiotic usage, and prevention of infection. Furthermore, their practice of using antibiotics, including previous antibiotic exposure, their antibiotic use during the past year, reasons for taking antibiotics, ways of obtaining antibiotics, and reasons for discontinuing of antibiotic therapy were also recorded. <b>Results:</b> The pre-intervention assessment revealed poor knowledge and practice regarding antibiotic use. Post-intervention, mean knowledge scores increased significantly from 18.36 to 23.28 (t = 19.5, <i>p</i> < 0.0001), while mean practice scores improved from 9.83 to 12.37 (t = 6.4, <i>p</i> < 0.0001). <b>Conclusions:</b> The intervention successfully improved caregivers' knowledge and practices regarding AMR. However, there are some limitations that could affect the generalization, and the impact of the results such as the relatively small sample size recruited from a single center, lack of a control group, reliance on self-reported data, and lack of long-term follow-up. Future studies should aim to address these constraints in order to assess the intervention's effectiveness.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 12","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11672425/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consortium of Lactobacillus crispatus 2029 and Ligilactobacillus salivarius 7247 Strains Shows In Vitro Bactericidal Effect on Campylobacter jejuni and, in Combination with Prebiotic, Protects Against Intestinal Barrier Dysfunction. criscrisbacillus 2029和liilactobacillus salivarius 7247联合菌株对空肠弯曲杆菌具有体外杀菌作用,并与益生元联合对肠道屏障功能障碍具有保护作用。
IF 4.3 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-11-28 DOI: 10.3390/antibiotics13121143
Vyacheslav M Abramov, Igor V Kosarev, Andrey V Machulin, Evgenia I Deryusheva, Tatiana V Priputnevich, Alexander N Panin, Irina O Chikileva, Tatiana N Abashina, Ashot M Manoyan, Olga E Ivanova, Tigran T Papazyan, Ilia N Nikonov, Nataliya E Suzina, Vyacheslav G Melnikov, Valentin S Khlebnikov, Vadim K Sakulin, Vladimir A Samoilenko, Alexey B Gordeev, Gennady T Sukhikh, Vladimir N Uversky, Andrey V Karlyshev
<p><p><b>Background/Objectives:</b><i>Campylobacter jejuni</i> (CJ) is the etiological agent of the world's most common intestinal infectious food-borne disease, ranging from mild symptoms to fatal outcomes. The development of innovative synbiotics that inhibit the adhesion and reproduction of multidrug-resistant (MDR) CJ in animals and humans, thereby preserving intestinal homeostasis, is relevant. We have created a synbiotic based on the consortium of <i>Lactobacillus crispatus</i> 2029 (LC2029), <i>Ligilactobacillus salivarius</i> 7247 (LS7247), and a mannan-rich prebiotic (Actigen<sup>®</sup>). The purpose of this work was to study the in vitro anti-adhesive and antagonistic activities of the created synbiotic against MDR CJ strains, along with its role in preventing intestinal barrier dysfunction, which disrupts intestinal homeostasis. <b>Methods:</b> A complex of microbiological, immunological, and molecular biological methods was used. The ability of the LC2029 and LS7247 consortium to promote intestinal homeostasis in vitro was assessed by the effectiveness of controlling CJ-induced TLR4 activation, secretion of pro-inflammatory cytokines, development of intestinal barrier dysfunction, and production of intestinal alkaline phosphatase (IAP). <b>Results:</b> All MDR CJ strains showed marked adhesion to human Caco-2, pig IPEC-J2, chicken CPCE, and bovine BPCE enterocytes. For the first time, we found that the prebiotic and cell-free culture supernatant (CFS) from the consortium of LC2029 and LS7247 strains exhibit an additive effect in inhibiting the adhesion of MDR strains of CJ to human and animal enterocytes. CFS from the LC2029 and LS7247 consortium increased the permeability of the outer and inner membranes of CJ cells, which led to extracellular leakage of ATP and provided access to the peptidoglycan of the pathogen for the peptidoglycan-degrading bacteriocins nisin and enterolysin A produced by LS7247. The LC2029 and LS7247 consortium showed a bactericidal effect on CJ strains. Co-cultivation of the consortium with CJ strains resulted in a decrease in the viability of the pathogen by 6 log. CFS from the LC2029 and LS7247 consortium prevented the growth of CJ-induced TLR4 mRNA expression in enterocytes. The LC2029 and LS7247 consortium inhibited a CJ-induced increase in IL-8 and TNF-α production in enterocytes, prevented CJ-induced intestinal barrier dysfunction, maintained the transepithelial electrical resistance of the enterocyte monolayers, and prevented an increase in intestinal paracellular permeability and zonulin secretion. CFS from the consortium stimulated IAP mRNA expression in enterocytes. The LC2029 and LS7247 consortium and the prebiotic Actigen represent a new synergistic synbiotic with anti-CJ properties that prevents intestinal barrier dysfunction and preserves intestinal homeostasis. <b>Conclusions:</b> These data highlight the potential of using a synergistic synbiotic as a preventive strategy for creating feed addi
背景/目的:空肠弯曲杆菌(CJ)是世界上最常见的肠道传染性食源性疾病的病原,从轻微症状到致命结果不等。开发能够抑制耐多药(MDR) CJ在动物和人体内的粘附和繁殖,从而保持肠道内稳态的创新合生剂具有重要意义。我们基于crispatus Lactobacillus 2029 (LC2029), liilactobacillus salivarius 7247 (LS7247)和富含甘露聚糖的益生元(Actigen®)的联盟创建了一种合成菌。本研究的目的是研究所制备的合成物对MDR CJ菌株的体外抗黏附和拮抗活性,以及其在预防肠道屏障功能障碍(破坏肠道内稳态)中的作用。方法:采用微生物学、免疫学和分子生物学的综合方法。通过控制cj诱导的TLR4激活、促炎细胞因子分泌、肠道屏障功能障碍的发生和肠道碱性磷酸酶(IAP)的产生,来评估LC2029和LS7247联合体体外促进肠道内稳态的能力。结果:所有MDR CJ菌株对人Caco-2、猪IPEC-J2、鸡CPCE和牛BPCE肠细胞均有明显粘附。本研究首次发现LC2029和LS7247菌株联合培养的益生元和无细胞培养上清(CFS)对抑制耐多药CJ菌株对人和动物肠细胞的粘附具有加性作用。LC2029和LS7247的CFS增加了CJ细胞内外膜的通透性,导致ATP在细胞外渗漏,并为LS7247产生的降解肽聚糖的细菌素nisin和肠溶素A提供了接近病原体肽聚糖的途径。LC2029和LS7247组合对CJ菌株有一定的杀菌作用。该菌群与CJ菌群共培养,病原菌活力降低6倍。LC2029和LS7247财团的CFS可阻止cj诱导的肠细胞TLR4 mRNA表达的增长。LC2029和LS7247联合抑制cj诱导的肠细胞IL-8和TNF-α产生的增加,阻止cj诱导的肠屏障功能障碍,维持肠细胞单层的经上皮电阻,并阻止肠细胞旁通透性和带蛋白分泌的增加。来自财团的CFS刺激肠细胞中IAP mRNA的表达。LC2029和LS7247联合体以及益生元Actigen代表了一种具有抗cj特性的新型协同合成物,可防止肠道屏障功能障碍并保持肠道内稳态。结论:这些数据突出了使用协同合成菌作为一种预防策略的潜力,可以在此基础上生产饲料添加剂和功能性营养产品,以对抗由耐多药菌株在动物和人类中引起的弯曲菌病的流行。
{"title":"Consortium of <i>Lactobacillus crispatus</i> 2029 and <i>Ligilactobacillus salivarius</i> 7247 Strains Shows In Vitro Bactericidal Effect on <i>Campylobacter jejuni</i> and, in Combination with Prebiotic, Protects Against Intestinal Barrier Dysfunction.","authors":"Vyacheslav M Abramov, Igor V Kosarev, Andrey V Machulin, Evgenia I Deryusheva, Tatiana V Priputnevich, Alexander N Panin, Irina O Chikileva, Tatiana N Abashina, Ashot M Manoyan, Olga E Ivanova, Tigran T Papazyan, Ilia N Nikonov, Nataliya E Suzina, Vyacheslav G Melnikov, Valentin S Khlebnikov, Vadim K Sakulin, Vladimir A Samoilenko, Alexey B Gordeev, Gennady T Sukhikh, Vladimir N Uversky, Andrey V Karlyshev","doi":"10.3390/antibiotics13121143","DOIUrl":"https://doi.org/10.3390/antibiotics13121143","url":null,"abstract":"&lt;p&gt;&lt;p&gt;&lt;b&gt;Background/Objectives:&lt;/b&gt;&lt;i&gt;Campylobacter jejuni&lt;/i&gt; (CJ) is the etiological agent of the world's most common intestinal infectious food-borne disease, ranging from mild symptoms to fatal outcomes. The development of innovative synbiotics that inhibit the adhesion and reproduction of multidrug-resistant (MDR) CJ in animals and humans, thereby preserving intestinal homeostasis, is relevant. We have created a synbiotic based on the consortium of &lt;i&gt;Lactobacillus crispatus&lt;/i&gt; 2029 (LC2029), &lt;i&gt;Ligilactobacillus salivarius&lt;/i&gt; 7247 (LS7247), and a mannan-rich prebiotic (Actigen&lt;sup&gt;®&lt;/sup&gt;). The purpose of this work was to study the in vitro anti-adhesive and antagonistic activities of the created synbiotic against MDR CJ strains, along with its role in preventing intestinal barrier dysfunction, which disrupts intestinal homeostasis. &lt;b&gt;Methods:&lt;/b&gt; A complex of microbiological, immunological, and molecular biological methods was used. The ability of the LC2029 and LS7247 consortium to promote intestinal homeostasis in vitro was assessed by the effectiveness of controlling CJ-induced TLR4 activation, secretion of pro-inflammatory cytokines, development of intestinal barrier dysfunction, and production of intestinal alkaline phosphatase (IAP). &lt;b&gt;Results:&lt;/b&gt; All MDR CJ strains showed marked adhesion to human Caco-2, pig IPEC-J2, chicken CPCE, and bovine BPCE enterocytes. For the first time, we found that the prebiotic and cell-free culture supernatant (CFS) from the consortium of LC2029 and LS7247 strains exhibit an additive effect in inhibiting the adhesion of MDR strains of CJ to human and animal enterocytes. CFS from the LC2029 and LS7247 consortium increased the permeability of the outer and inner membranes of CJ cells, which led to extracellular leakage of ATP and provided access to the peptidoglycan of the pathogen for the peptidoglycan-degrading bacteriocins nisin and enterolysin A produced by LS7247. The LC2029 and LS7247 consortium showed a bactericidal effect on CJ strains. Co-cultivation of the consortium with CJ strains resulted in a decrease in the viability of the pathogen by 6 log. CFS from the LC2029 and LS7247 consortium prevented the growth of CJ-induced TLR4 mRNA expression in enterocytes. The LC2029 and LS7247 consortium inhibited a CJ-induced increase in IL-8 and TNF-α production in enterocytes, prevented CJ-induced intestinal barrier dysfunction, maintained the transepithelial electrical resistance of the enterocyte monolayers, and prevented an increase in intestinal paracellular permeability and zonulin secretion. CFS from the consortium stimulated IAP mRNA expression in enterocytes. The LC2029 and LS7247 consortium and the prebiotic Actigen represent a new synergistic synbiotic with anti-CJ properties that prevents intestinal barrier dysfunction and preserves intestinal homeostasis. &lt;b&gt;Conclusions:&lt;/b&gt; These data highlight the potential of using a synergistic synbiotic as a preventive strategy for creating feed addi","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 12","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11672454/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating Diagnostic Approaches in Infant Bacterial Meningitis Caused by a Non-K1 Escherichia coli: A Case Report. 非k1型大肠杆菌引起的婴儿细菌性脑膜炎的综合诊断方法:1例报告。
IF 4.3 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-11-28 DOI: 10.3390/antibiotics13121144
Gianluca Vrenna, Marilena Agosta, Valeria Fox, Martina Rossitto, Venere Cortazzo, Serena Raimondi, Barbara Lucignano, Manuela Onori, Livia Mancinelli, Maria Del Carmen Pereyra Boza, Vanessa Fini, Annarita Granaglia, Laura Lancella, Francesca Ippolita Calo' Carducci, Costanza Tripiciano, Alberto Villani, Paola Bernaschi, Carlo Federico Perno

Background: Infant meningitis, particularly caused by Escherichia coli, remains a life-threatening condition, especially in premature and low-weight infants. Infections of the central nervous system can be fatal, necessitating prompt diagnosis and appropriate treatment. Acute infections caused by various pathogens, including E. coli, often present with similar clinical symptoms. The rapid identification of pathogens and their antimicrobial resistance mechanisms is critical for timely and effective treatment. We report the case of an 8-month-old patient who presented with fever, diarrhea, and convulsive seizures and was subsequently diagnosed with meningitis. Despite initial empirical treatment with ceftriaxone, the patient's condition worsened.

Methods: At Bambino Gesù Children's Hospital, molecular diagnostic tools, including the FilmArray Meningitis/Encephalitis and Blood Culture Identification panels, were employed.

Results: Although the Meningitis panel did not detect any pathogens due to the lack of the specific bacterial target, the off-label use of the Blood Culture Identification panel identified a non-K1 Escherichia coli strain carrying the CTX-M resistance gene, an extended-spectrum beta-lactamase (ESBL). Despite the rapid diagnostic approach and adjustment of antibiotic therapy, the patient succumbed to the infection due to the strain's high virulence and multidrug resistance. Whole-genome sequencing further characterized the strain, revealing that it belonged to the ST131 group, a highly resistant and virulent strain associated with sepsis.

Conclusions: This case highlights the importance of integrating advanced molecular diagnostics, such as whole-genome sequencing, with traditional methods to improve pathogen detection, especially in cases of emerging resistant strains that are not covered by standard diagnostic panels. It also emphasizes the need for the continuous adaptation of diagnostic tools to include non-K1 E. coli strains for more comprehensive and timely meningitis diagnosis.

背景:婴儿脑膜炎,特别是由大肠杆菌引起的,仍然是一种危及生命的疾病,特别是在早产儿和低体重婴儿中。中枢神经系统感染可能是致命的,需要及时诊断和适当治疗。由各种病原体引起的急性感染,包括大肠杆菌,通常表现出相似的临床症状。快速鉴定病原菌及其耐药机制对及时有效治疗至关重要。我们报告一例8个月大的病人,他表现出发烧、腹泻和惊厥发作,随后被诊断为脑膜炎。尽管最初使用头孢曲松进行经验性治疗,但患者病情恶化。方法:在Bambino Gesù儿童医院,采用分子诊断工具,包括FilmArray脑膜炎/脑炎和血培养鉴定板。结果:尽管由于缺乏特定的细菌靶标,脑膜炎小组没有检测到任何病原体,但在标签外使用的血培养鉴定小组发现了一种携带CTX-M耐药基因的非k1大肠杆菌菌株,这是一种广谱β -内酰胺酶(ESBL)。尽管采用了快速诊断方法并调整了抗生素治疗,但由于该菌株的高毒力和多药耐药,患者还是死于感染。全基因组测序进一步确定了该菌株的特征,显示它属于ST131组,这是一种与败血症相关的高抗性和毒性菌株。结论:该病例强调了将先进的分子诊断(如全基因组测序)与传统方法相结合以提高病原体检测的重要性,特别是在标准诊断小组未涵盖的新出现耐药菌株的情况下。它还强调需要不断调整诊断工具,以包括非k1大肠杆菌菌株,以便更全面和及时地诊断脑膜炎。
{"title":"Integrating Diagnostic Approaches in Infant Bacterial Meningitis Caused by a Non-K1 <i>Escherichia coli</i>: A Case Report.","authors":"Gianluca Vrenna, Marilena Agosta, Valeria Fox, Martina Rossitto, Venere Cortazzo, Serena Raimondi, Barbara Lucignano, Manuela Onori, Livia Mancinelli, Maria Del Carmen Pereyra Boza, Vanessa Fini, Annarita Granaglia, Laura Lancella, Francesca Ippolita Calo' Carducci, Costanza Tripiciano, Alberto Villani, Paola Bernaschi, Carlo Federico Perno","doi":"10.3390/antibiotics13121144","DOIUrl":"https://doi.org/10.3390/antibiotics13121144","url":null,"abstract":"<p><strong>Background: </strong>Infant meningitis, particularly caused by <i>Escherichia coli</i>, remains a life-threatening condition, especially in premature and low-weight infants. Infections of the central nervous system can be fatal, necessitating prompt diagnosis and appropriate treatment. Acute infections caused by various pathogens, including <i>E. coli</i>, often present with similar clinical symptoms. The rapid identification of pathogens and their antimicrobial resistance mechanisms is critical for timely and effective treatment. We report the case of an 8-month-old patient who presented with fever, diarrhea, and convulsive seizures and was subsequently diagnosed with meningitis. Despite initial empirical treatment with ceftriaxone, the patient's condition worsened.</p><p><strong>Methods: </strong>At Bambino Gesù Children's Hospital, molecular diagnostic tools, including the FilmArray Meningitis/Encephalitis and Blood Culture Identification panels, were employed.</p><p><strong>Results: </strong>Although the Meningitis panel did not detect any pathogens due to the lack of the specific bacterial target, the off-label use of the Blood Culture Identification panel identified a non-K1 <i>Escherichia coli</i> strain carrying the CTX-M resistance gene, an extended-spectrum beta-lactamase (ESBL). Despite the rapid diagnostic approach and adjustment of antibiotic therapy, the patient succumbed to the infection due to the strain's high virulence and multidrug resistance. Whole-genome sequencing further characterized the strain, revealing that it belonged to the ST131 group, a highly resistant and virulent strain associated with sepsis.</p><p><strong>Conclusions: </strong>This case highlights the importance of integrating advanced molecular diagnostics, such as whole-genome sequencing, with traditional methods to improve pathogen detection, especially in cases of emerging resistant strains that are not covered by standard diagnostic panels. It also emphasizes the need for the continuous adaptation of diagnostic tools to include non-K1 <i>E. coli</i> strains for more comprehensive and timely meningitis diagnosis.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 12","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11672694/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic and Surgical Treatment of Diabetic Foot Osteomyelitis: The Histopathological Evidence. 糖尿病足骨髓炎的抗生素和手术治疗:组织病理学证据。
IF 4.3 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-11-27 DOI: 10.3390/antibiotics13121142
Roberto Da Ros, Roberta Assaloni, Andrea Michelli, Barbara Brunato, Cesare Miranda

Background: Osteomyelitis is one of the most frequent infections of the diabetic foot, accounting for 20-70% of foot infections. The treatment of osteomyelitis continues to be debated, and the possibility of performing conservative surgery associated with targeted antibiotic treatment allows for reductions in the amount of bone removed, the resolution of osteomyelitis, and a reduction in the changes in the biomechanics of the foot. The objective of this study was to evaluate the outcomes of osteomyelitis treatment with a combination of antibiotic and surgical procedures based on a histopathological analysis of the infected bone and margins. Materials and Methods: We analyzed 25 diabetic patients with osteomyelitis. We treated each patient with empiric antibiotic treatment, surgical removal of the infected bone, and targeted antibiotic treatment. During the surgical procedure, we collected infected bone samples and margins for microbiological and histopathological analyses. Results: All the patients had type 2 diabetes, with a mean age of 71 ± 10 years. Antibiotic therapy was administered orally for an average duration of 21 ± 9 days, aimed at improving the microbiological outcome. Histological examinations of the resected infected bone revealed the presence of osteomyelitis in 23 (92%) patients. The healthy margin sample, surgically assessed as non-infected, was confirmed negative in 80% of cases. At a follow-up of 18 ± 7 months, we achieved complete healing in twenty patients (80%), with an average healing time of 70 ± 41 days. No recurrence of osteomyelitis was observed. Conclusions: The data from this study demonstrate that the combination of targeted antibiotic therapy and conservative surgical treatment is effective in resolving osteomyelitis without recurrence with a very long follow-up. Histological analyses allowed us to confirm the actual presence of osteomyelitis and demonstrate that clinical differentiation during surgery is effective in identifying a healthy margin.

背景:骨髓炎是糖尿病足最常见的感染之一,占足部感染的20-70%。骨髓炎的治疗方法仍然存在争议,保守手术结合靶向抗生素治疗的可能性可以减少骨移除量,骨髓炎的解决,并减少足部生物力学的变化。本研究的目的是根据感染骨和边缘的组织病理学分析,评估抗生素和外科手术联合治疗骨髓炎的结果。材料与方法:对25例合并骨髓炎的糖尿病患者进行分析。我们对每位患者进行经验性抗生素治疗、手术切除感染骨和靶向抗生素治疗。在手术过程中,我们收集了受感染的骨样本和边缘进行微生物学和组织病理学分析。结果:所有患者均为2型糖尿病,平均年龄71±10岁。口服抗生素治疗平均持续时间为21±9天,旨在改善微生物学结果。对切除感染骨的组织学检查显示23例(92%)患者存在骨髓炎。手术评估为未感染的健康切缘样本在80%的病例中被证实为阴性。随访18±7个月,20例(80%)患者完全愈合,平均愈合时间70±41天。未见骨髓炎复发。结论:本研究数据表明,联合靶向抗生素治疗和保守手术治疗能有效解决骨髓炎,无复发,随访时间长。组织学分析使我们能够确认骨髓炎的实际存在,并证明手术期间的临床鉴别对于确定健康的切缘是有效的。
{"title":"Antibiotic and Surgical Treatment of Diabetic Foot Osteomyelitis: The Histopathological Evidence.","authors":"Roberto Da Ros, Roberta Assaloni, Andrea Michelli, Barbara Brunato, Cesare Miranda","doi":"10.3390/antibiotics13121142","DOIUrl":"https://doi.org/10.3390/antibiotics13121142","url":null,"abstract":"<p><p><b>Background:</b> Osteomyelitis is one of the most frequent infections of the diabetic foot, accounting for 20-70% of foot infections. The treatment of osteomyelitis continues to be debated, and the possibility of performing conservative surgery associated with targeted antibiotic treatment allows for reductions in the amount of bone removed, the resolution of osteomyelitis, and a reduction in the changes in the biomechanics of the foot. The objective of this study was to evaluate the outcomes of osteomyelitis treatment with a combination of antibiotic and surgical procedures based on a histopathological analysis of the infected bone and margins. <b>Materials and Methods:</b> We analyzed 25 diabetic patients with osteomyelitis. We treated each patient with empiric antibiotic treatment, surgical removal of the infected bone, and targeted antibiotic treatment. During the surgical procedure, we collected infected bone samples and margins for microbiological and histopathological analyses. <b>Results:</b> All the patients had type 2 diabetes, with a mean age of 71 ± 10 years. Antibiotic therapy was administered orally for an average duration of 21 ± 9 days, aimed at improving the microbiological outcome. Histological examinations of the resected infected bone revealed the presence of osteomyelitis in 23 (92%) patients. The healthy margin sample, surgically assessed as non-infected, was confirmed negative in 80% of cases. At a follow-up of 18 ± 7 months, we achieved complete healing in twenty patients (80%), with an average healing time of 70 ± 41 days. No recurrence of osteomyelitis was observed. <b>Conclusions:</b> The data from this study demonstrate that the combination of targeted antibiotic therapy and conservative surgical treatment is effective in resolving osteomyelitis without recurrence with a very long follow-up. Histological analyses allowed us to confirm the actual presence of osteomyelitis and demonstrate that clinical differentiation during surgery is effective in identifying a healthy margin.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 12","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11672856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National Multicenter Study on the Prevalence of Carbapenemase-Producing Enterobacteriaceae in the Post-COVID-19 Era in Argentina: The RECAPT-AR Study. 阿根廷后covid -19时代产碳青霉烯酶肠杆菌科流行的国家多中心研究:RECAPT-AR研究
IF 4.3 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-11-27 DOI: 10.3390/antibiotics13121139
Mariano Echegorry, Paulina Marchetti, Cristian Sanchez, Laura Olivieri, Diego Faccone, Florencia Martino, Tomas Sarkis Badola, Paola Ceriana, Melina Rapoport, Celeste Lucero, Ezequiel Albornoz, Recapt-Ar Group, Alejandra Corso, Fernando Pasteran

The COVID-19 pandemic has exacerbated the global antimicrobial resistance (AMR) crisis. Consequently, it is more urgent than ever to prioritize AMR containment and support countries in improving the detection, characterization, and rapid response to emerging AMR threats. We conducted a prospective, multicenter study to assess the prevalence of carbapenemase-producing Enterobacterales in infectious processes in Argentina during the post-COVID-19 pandemic period and explore therapeutic alternatives for their treatment (RECAPT-AR study).

Methods: A total of 182 hospitals participated by submitting Enterobacterales clinical isolates to the National Reference Laboratory (NRL) during the first three weeks of November 2021. Inclusion criteria were defined as an ertapenem MIC ≥ 0.5 mg/L, a zone diameter ≤ 22 mm. Carbapenemase genes and those coding for major extended-spectrum β-lactamases were molecularly characterized using multiplex PCR at the NRL. Antibiotic susceptibility testing followed international standards (CLSI and EUCAST).

Results: The NRL analyzed 821 Enterobacterales isolates. Metallo-β-lactamase (MBL, 42.0%) and KPC (39.8%) accounted for 81.8% of carbapenemases, followed by OXA-163 (7.4%), a variant of OXA-48 with additional activity against extended-spectrum cephalosporins, and enzyme combinations (8.3%). These combinations included NDM plus KPC (3.4%), OXA-163 plus KPC (2.4%), and OXA-163 plus NDM (2.1%). Klebsiella pneumoniae was the main species recovered, representing 76% of the isolates. According to the carbapenemase classes or combinations, tigecycline exhibited a susceptibility range of 33-83%, fosfomycin 59-81%, colistin 27-78%, and amikacin 17-81%. Ceftazidime-avibactam (CZA) and imipenem-relebactam (IMR) showed 92% and 98% susceptibility against serine carbapenemases, respectively. Meanwhile, aztreonam-avibactam (AZA) exhibited 96-98% susceptibility against all carbapenemase classes.

Conclusions: A new epidemiological landscape has emerged, characterized by the equivalent circulation of NDM and KPC. K. pneumoniae remains the primary species responsible for their dissemination. The co-production of carbapenemase combinations, particularly KPC plus NDM, was confirmed, mainly in K. pneumoniae. High activity was observed for AZA against MBLs and for CZA and IMR against KPC and OXA-163 carbapenemases.

2019冠状病毒病大流行加剧了全球抗微生物药物耐药性(AMR)危机。因此,比以往任何时候都更迫切需要优先考虑遏制抗菌素耐药性,并支持各国改进对新出现的抗菌素耐药性威胁的检测、定性和快速反应。我们开展了一项前瞻性、多中心研究,以评估2019冠状病毒病大流行后阿根廷感染过程中产碳青霉烯酶肠杆菌的流行情况,并探索其治疗方案(RECAPT-AR研究)。方法:共有182家医院于2021年11月前三周向国家参考实验室(NRL)提交肠杆菌临床分离株。纳入标准定义为厄他培南MIC≥0.5 mg/L,带直径≤22 mm。碳青霉烯酶基因和主要扩展谱β-内酰胺酶编码基因在NRL采用多重PCR进行了分子表征。药敏试验按国际标准(CLSI和EUCAST)进行。结果:NRL共分离出821株肠杆菌。金属β-内酰胺酶(MBL, 42.0%)和KPC(39.8%)占碳青霉烯酶的81.8%,其次是OXA-163 (7.4%), OXA-48的一个变体,对广谱头孢菌素具有额外的活性,以及酶组合(8.3%)。这些组合包括NDM + KPC(3.4%)、OXA-163 + KPC(2.4%)和OXA-163 + NDM(2.1%)。肺炎克雷伯菌是回收的主要菌种,占分离株的76%。根据碳青霉烯酶的类别或组合,替加环素的敏感性范围为33-83%,磷霉素为59-81%,粘菌素为27-78%,阿米卡星为17-81%。头孢他啶-阿维巴坦(CZA)和亚胺培南-勒巴坦(IMR)对丝氨酸碳青霉烯酶的敏感性分别为92%和98%。aztreonam-avibactam (AZA)对碳青霉烯酶的敏感性为96% ~ 98%。结论:一种新的流行病学格局已经出现,其特征是NDM和KPC的等效循环。肺炎克雷伯菌仍然是导致其传播的主要物种。碳青霉烯酶组合,特别是KPC加NDM,主要在肺炎克雷伯菌中被证实共同产生。观察到AZA对MBLs的高活性,CZA和IMR对KPC和OXA-163碳青霉烯酶的高活性。
{"title":"National Multicenter Study on the Prevalence of Carbapenemase-Producing Enterobacteriaceae in the Post-COVID-19 Era in Argentina: The RECAPT-AR Study.","authors":"Mariano Echegorry, Paulina Marchetti, Cristian Sanchez, Laura Olivieri, Diego Faccone, Florencia Martino, Tomas Sarkis Badola, Paola Ceriana, Melina Rapoport, Celeste Lucero, Ezequiel Albornoz, Recapt-Ar Group, Alejandra Corso, Fernando Pasteran","doi":"10.3390/antibiotics13121139","DOIUrl":"https://doi.org/10.3390/antibiotics13121139","url":null,"abstract":"<p><p>The COVID-19 pandemic has exacerbated the global antimicrobial resistance (AMR) crisis. Consequently, it is more urgent than ever to prioritize AMR containment and support countries in improving the detection, characterization, and rapid response to emerging AMR threats. We conducted a prospective, multicenter study to assess the prevalence of carbapenemase-producing Enterobacterales in infectious processes in Argentina during the post-COVID-19 pandemic period and explore therapeutic alternatives for their treatment (RECAPT-AR study).</p><p><strong>Methods: </strong>A total of 182 hospitals participated by submitting Enterobacterales clinical isolates to the National Reference Laboratory (NRL) during the first three weeks of November 2021. Inclusion criteria were defined as an ertapenem MIC ≥ 0.5 mg/L, a zone diameter ≤ 22 mm. Carbapenemase genes and those coding for major extended-spectrum β-lactamases were molecularly characterized using multiplex PCR at the NRL. Antibiotic susceptibility testing followed international standards (CLSI and EUCAST).</p><p><strong>Results: </strong>The NRL analyzed 821 Enterobacterales isolates. Metallo-β-lactamase (MBL, 42.0%) and KPC (39.8%) accounted for 81.8% of carbapenemases, followed by OXA-163 (7.4%), a variant of OXA-48 with additional activity against extended-spectrum cephalosporins, and enzyme combinations (8.3%). These combinations included NDM plus KPC (3.4%), OXA-163 plus KPC (2.4%), and OXA-163 plus NDM (2.1%). <i>Klebsiella pneumoniae</i> was the main species recovered, representing 76% of the isolates. According to the carbapenemase classes or combinations, tigecycline exhibited a susceptibility range of 33-83%, fosfomycin 59-81%, colistin 27-78%, and amikacin 17-81%. Ceftazidime-avibactam (CZA) and imipenem-relebactam (IMR) showed 92% and 98% susceptibility against serine carbapenemases, respectively. Meanwhile, aztreonam-avibactam (AZA) exhibited 96-98% susceptibility against all carbapenemase classes.</p><p><strong>Conclusions: </strong>A new epidemiological landscape has emerged, characterized by the equivalent circulation of NDM and KPC. <i>K. pneumoniae</i> remains the primary species responsible for their dissemination. The co-production of carbapenemase combinations, particularly KPC plus NDM, was confirmed, mainly in <i>K. pneumoniae</i>. High activity was observed for AZA against MBLs and for CZA and IMR against KPC and OXA-163 carbapenemases.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 12","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11672406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Knowledge on CRISPR Strategies Against Antimicrobial-Resistant Bacteria. 抗微生物耐药细菌CRISPR策略的最新进展
IF 4.3 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-11-27 DOI: 10.3390/antibiotics13121141
Carlos de la Fuente Tagarro, Diego Martín-González, Andrea De Lucas, Sergio Bordel, Fernando Santos-Beneit

CRISPR/Cas systems have emerged as valuable tools to approach the problem of antimicrobial resistance by either sensitizing or lysing resistant bacteria or by aiding in antibiotic development, with successful applications across diverse organisms, including bacteria and fungi. CRISPR/Cas systems can target plasmids or the bacterial chromosome of AMR-bacteria, and it is especially necessary to have an efficient entry into the target cells, which can be achieved through nanoparticles or bacteriophages. Regarding antibiotic development and production, though the use of CRISPR/Cas in this field is still modest, there is an untapped reservoir of bacterial and fungal natural products, with over 95% yet to be characterized. In Streptomyces, a key antibiotic-producing bacterial genus, CRISPR/Cas has been successfully used to activate silent biosynthetic gene clusters, leading to the discovery of new antibiotics. CRISPR/Cas is also applicable to non-model bacteria and different species of fungi, making it a versatile tool for natural products discovery. Moreover, CRISPR/Cas-based studies offer insights into metabolic regulation and biosynthetic pathways in both bacteria and fungi, highlighting its utility in understanding genetic regulation and improving industrial strains. In this work, we review ongoing innovations on ways to treat antimicrobial resistances and on antibiotic discovery using CRISPR/Cas platforms, highlighting the role of bacteria and fungi in these processes.

CRISPR/Cas系统已经成为解决抗菌素耐药性问题的有价值的工具,通过致敏或裂解耐药细菌或帮助抗生素开发,已成功应用于包括细菌和真菌在内的多种生物。CRISPR/Cas系统可以靶向amr细菌的质粒或细菌染色体,尤其需要高效进入靶细胞,这可以通过纳米颗粒或噬菌体来实现。在抗生素的开发和生产方面,尽管CRISPR/Cas在这一领域的应用仍然有限,但细菌和真菌的天然产物尚未开发,95%以上尚未表征。在链霉菌(Streptomyces)中,CRISPR/Cas已被成功用于激活沉默的生物合成基因簇,从而发现新的抗生素。CRISPR/Cas也适用于非模式细菌和不同种类的真菌,使其成为天然产物发现的多功能工具。此外,基于CRISPR/ cas的研究为细菌和真菌的代谢调控和生物合成途径提供了见解,突出了其在理解遗传调控和改进工业菌株方面的实用性。在这项工作中,我们回顾了使用CRISPR/Cas平台治疗抗菌素耐药性的方法和抗生素发现的持续创新,强调了细菌和真菌在这些过程中的作用。
{"title":"Current Knowledge on CRISPR Strategies Against Antimicrobial-Resistant Bacteria.","authors":"Carlos de la Fuente Tagarro, Diego Martín-González, Andrea De Lucas, Sergio Bordel, Fernando Santos-Beneit","doi":"10.3390/antibiotics13121141","DOIUrl":"https://doi.org/10.3390/antibiotics13121141","url":null,"abstract":"<p><p>CRISPR/Cas systems have emerged as valuable tools to approach the problem of antimicrobial resistance by either sensitizing or lysing resistant bacteria or by aiding in antibiotic development, with successful applications across diverse organisms, including bacteria and fungi. CRISPR/Cas systems can target plasmids or the bacterial chromosome of AMR-bacteria, and it is especially necessary to have an efficient entry into the target cells, which can be achieved through nanoparticles or bacteriophages. Regarding antibiotic development and production, though the use of CRISPR/Cas in this field is still modest, there is an untapped reservoir of bacterial and fungal natural products, with over 95% yet to be characterized. In <i>Streptomyces</i>, a key antibiotic-producing bacterial genus, CRISPR/Cas has been successfully used to activate silent biosynthetic gene clusters, leading to the discovery of new antibiotics. CRISPR/Cas is also applicable to non-model bacteria and different species of fungi, making it a versatile tool for natural products discovery. Moreover, CRISPR/Cas-based studies offer insights into metabolic regulation and biosynthetic pathways in both bacteria and fungi, highlighting its utility in understanding genetic regulation and improving industrial strains. In this work, we review ongoing innovations on ways to treat antimicrobial resistances and on antibiotic discovery using CRISPR/Cas platforms, highlighting the role of bacteria and fungi in these processes.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 12","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11672446/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antimicrobial Resistance in African Great Apes. 非洲类人猿的抗菌素耐药性。
IF 4.3 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-11-27 DOI: 10.3390/antibiotics13121140
Coch Tanguy Floyde Tanga, Patrice Makouloutou-Nzassi, Pierre Philippe Mbehang Nguema, Ariane Düx, Silas Lendzele Sevidzem, Jacques François Mavoungou, Fabian H Leendertz, Rodrigue Mintsa-Nguema

Background/objectives: Antibiotic-resistant bacteria pose a significant global public health threat that demands serious attention. The proliferation of antimicrobial resistance (AMR) is primarily attributed to the overuse of antibiotics in humans, livestock, and the agro-industry. However, it is worth noting that antibiotic-resistant genes (ARGs) can be found in all ecosystems, even in environments where antibiotics have never been utilized. African great apes (AGAs) are our closest living relatives and are known to be susceptible to many of the same pathogens (and other microorganisms) as humans. AGAs could therefore serve as sentinels for human-induced AMR spread into the environment. They can potentially also serve as reservoirs for AMR. AGAs inhabit a range of environments from remote areas with little anthropogenic impact, over habitats that are co-used by AGAs and humans, to captive settings with close human-animal contacts like zoos and sanctuaries. This provides opportunities to study AMR in relation to human interaction. This review examines the literature on AMR in AGAs, identifying knowledge gaps.

Results: Of the 16 articles reviewed, 13 focused on wild AGAs in habitats with different degrees of human presence, 2 compared wild and captive apes, and 1 study tested captive apes alone. Ten studies included humans working with or living close to AGA habitats. Despite different methodologies, all studies detected AMR in AGAs. Resistance to beta-lactams was the most common (36%), followed by resistance to aminoglycosides (22%), tetracyclines (15%), fluoroquinolones (10%), sulphonamides (5%), trimethoprim (5%), macrolide (3%), phenicoles (2%) and fosfomycin (1%).

Conclusions: While several studies suggest a correlation between increased human contact and higher AMR in AGAs, resistance was also found in relatively pristine habitats. While AGAs clearly encounter bacteria resistant to diverse antibiotics, significant gaps remain in understanding the underlying processes. Comparative studies using standardized methods across different sites would enhance our understanding of the origin and distribution of AMR in AGAs.

背景/目的:耐抗生素细菌对全球公共卫生构成重大威胁,需要引起高度重视。抗菌素耐药性(AMR)的扩散主要归因于人类、牲畜和农业工业中抗生素的过度使用。然而,值得注意的是,抗生素耐药基因(ARGs)可以在所有生态系统中找到,即使在从未使用抗生素的环境中也是如此。非洲类人猿(AGAs)是我们最亲近的亲戚,众所周知,它们对许多与人类相同的病原体(和其他微生物)很敏感。因此,AGAs可以作为人类诱导的抗菌素耐药性扩散到环境中的哨兵。它们也可能成为抗菌素耐药性的宿主。AGAs生活在各种环境中,从几乎没有人为影响的偏远地区,到AGAs和人类共同使用的栖息地,再到动物园和保护区等人兽密切接触的圈养环境。这为研究与人类互动有关的抗菌素耐药性提供了机会。本文回顾了AGAs中抗菌素耐药性的文献,确定了知识空白。结果:16篇文献中,13篇聚焦于不同人类存在程度生境下的野生AGAs, 2篇比较野生与圈养类人猿,1篇单独考察圈养类人猿。10项研究包括与AGA栖息地工作或生活在其附近的人类。尽管方法不同,但所有研究都检测到了AGAs中的AMR。对-内酰胺类药物的耐药最为常见(36%),其次是氨基糖苷类药物(22%)、四环素类药物(15%)、氟喹诺酮类药物(10%)、磺胺类药物(5%)、甲氧苄啶(5%)、大环内酯类药物(3%)、phenicoles(2%)和磷霉素(1%)。结论:虽然几项研究表明人类接触增加与AGAs较高的抗菌素耐药性之间存在相关性,但在相对原始的栖息地也发现了耐药性。虽然AGAs显然会遇到对多种抗生素具有耐药性的细菌,但在了解其潜在过程方面仍存在重大差距。采用标准化方法进行不同位点间的比较研究,有助于加深对AGAs中抗菌素耐药性起源和分布的认识。
{"title":"Antimicrobial Resistance in African Great Apes.","authors":"Coch Tanguy Floyde Tanga, Patrice Makouloutou-Nzassi, Pierre Philippe Mbehang Nguema, Ariane Düx, Silas Lendzele Sevidzem, Jacques François Mavoungou, Fabian H Leendertz, Rodrigue Mintsa-Nguema","doi":"10.3390/antibiotics13121140","DOIUrl":"https://doi.org/10.3390/antibiotics13121140","url":null,"abstract":"<p><strong>Background/objectives: </strong>Antibiotic-resistant bacteria pose a significant global public health threat that demands serious attention. The proliferation of antimicrobial resistance (AMR) is primarily attributed to the overuse of antibiotics in humans, livestock, and the agro-industry. However, it is worth noting that antibiotic-resistant genes (ARGs) can be found in all ecosystems, even in environments where antibiotics have never been utilized. African great apes (AGAs) are our closest living relatives and are known to be susceptible to many of the same pathogens (and other microorganisms) as humans. AGAs could therefore serve as sentinels for human-induced AMR spread into the environment. They can potentially also serve as reservoirs for AMR. AGAs inhabit a range of environments from remote areas with little anthropogenic impact, over habitats that are co-used by AGAs and humans, to captive settings with close human-animal contacts like zoos and sanctuaries. This provides opportunities to study AMR in relation to human interaction. This review examines the literature on AMR in AGAs, identifying knowledge gaps.</p><p><strong>Results: </strong>Of the 16 articles reviewed, 13 focused on wild AGAs in habitats with different degrees of human presence, 2 compared wild and captive apes, and 1 study tested captive apes alone. Ten studies included humans working with or living close to AGA habitats. Despite different methodologies, all studies detected AMR in AGAs. Resistance to beta-lactams was the most common (36%), followed by resistance to aminoglycosides (22%), tetracyclines (15%), fluoroquinolones (10%), sulphonamides (5%), trimethoprim (5%), macrolide (3%), phenicoles (2%) and fosfomycin (1%).</p><p><strong>Conclusions: </strong>While several studies suggest a correlation between increased human contact and higher AMR in AGAs, resistance was also found in relatively pristine habitats. While AGAs clearly encounter bacteria resistant to diverse antibiotics, significant gaps remain in understanding the underlying processes. Comparative studies using standardized methods across different sites would enhance our understanding of the origin and distribution of AMR in AGAs.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 12","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11672706/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Antibiotics-Basel
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1